FLOVENT Hydrofluoroalkane (HFA) In 6-12 Month Old Subjects
Status:
Completed
Trial end date:
2007-04-12
Target enrollment:
Participant gender:
Summary
The purpose of this study is to address an Food Drug and Administration (FDA) request to
provide safety data in pre-asthmatic patients, ages 6 months to <12 months, following
administration of fluticasone propionate HFA.